Bernd Kasper

36PUBLICATIONS
131CO-AUTHORS
Solid tumoursMolecular targetsMajor global burdens of diseasePredictive and prognostic markersPrimary health care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Apr 24, 2026
Reply to: In DeFi-ance of "More Is Better": Questioning Long-Term Nirogacestat Use in Desmoid Tumors.

|Mar 28, 2026
The Health-Related Quality of Life of German Desmoid Patients: Results from the PROSa-DES and PROSa Study.

Martin Eichler, Rebekka Hoffmann, Christina Baumgarten

|Oct 20, 2025
Efficacy and Safety of Long-Term Continuous Nirogacestat Treatment in Adults With Desmoid Tumors: Results From the DeFi Trial.

Ravin Ratan, Bernd Kasper, Thierry Alcindor

|Jul 29, 2025
Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial).

Johanna Falkenhorst, Philipp Ivanyi, Tom Schulz

Pageof 6